Drugmaker to Test Machine Learning to Prevent Drug Shortages: Germany-based Merck plans to use analytics and machine learning to predict and prevent drug shortages, a move that could also save it money.
Source: wsj.com
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called "bad cholesterol," or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia.
Source: reuters.com